NEUROSENSE THERAPEUTICS LTD's ticker is and the CUSIP is M74240108. A total of 6 filers reported holding NEUROSENSE THERAPEUTICS LTD in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,862 | -16.2% | 9,665 | +103.0% | 0.00% | – |
| Q1 2023 | $8,191 | +65.2% | 4,762 | +17.1% | 0.00% | – |
| Q4 2022 | $4,959 | +65.3% | 4,065 | +122.5% | 0.00% | – |
| Q3 2022 | $3,000 | -93.3% | 1,827 | -86.4% | 0.00% | – |
| Q2 2022 | $45,000 | +542.9% | 13,428 | +612.7% | 0.00% | – |
| Q1 2022 | $7,000 | -65.0% | 1,884 | -76.5% | 0.00% | – |
| Q4 2021 | $20,000 | – | 8,018 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vanguard Personalized Indexing Management, LLC | 39,634 | $134,000 | 0.01% |
| CLEAR STREET LLC | 7,157 | $24,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 9,794 | $33,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 20,259 | $68,000 | 0.00% |
| CITIGROUP INC | 49,744 | $168,000 | 0.00% |
| JANE STREET GROUP, LLC | 77,249 | $261,000 | 0.00% |
| UBS Group AG | 13,428 | $45,000 | 0.00% |